Myelofibrosis and JAK Mutations: Everything You Need to Know

Watch Myelofibrosis and JAK Mutations: Everything You Need to Know featuring Dr. Abdulraheem Yacoub, an expert hematologist and oncologist who is certified by the American Board of Internal Medicine. Dr. Yacoub specializes in myeloproliferative disorders such as myelofibrosis. Myelofibrosis and JAK Mutations: Everything You Need to Know was hosted by Jackie Bement, Patient Relations Coordinator at Massive Bio. Like the Massive Bio Facebook page to get notified about future events with our oncology experts. Fill out the form on this page to watch the full event. Topics that were covered include: 

• Overview of myelofibrosis and it’s progression 
• What are JAK mutations and how common are they in myelofibrosis? 
• How JAK mutations effect myelofibrosis prognosis 
• How to get genomic testing for cancer patients 
• What are JAK inhibitors and how do they treat myelofibrosis? 
• Treatments for myelofibrosis without JAK mutations 

Clinical trials test the latest scientific advancements in myelofibrosis treatment. Patients who choose to enroll in trials can receive cutting-edge treatment and high-quality care under the direction of scientists, doctors, and researchers. Myelofibrosis patients might gain access to promising drugs and innovative treatments long before they’re made available to the public. During the event, we will also take questions directly from the community on topics such as myelofibrosis clinical trials, JAK mutations, genomic testing, and targeted therapies. At the end of the event, the live Q&A will answer all submissions. 

With Massive Bio’s AI technology, finding a clinical trial doesn’t have to be difficult or time consuming for patients or their physicians. Let us help you and your patients find the best trial within 48 hours of receipt of records. Myelofibrosis and JAK Mutations: Everything You Need to Know was live on Monday, December 20th at 11:00 am EST. Fill out the form to get the full event video. Watch to learn about myelofibrosis clinical trials, JAK mutations, how Massive Bio can help myelofibrosis patients, and more!